All News

A new study says that treating iron deficiency therapy may improve outcomes in patients with chronic kidney disease, even if they don’t have anemia.

In a recent review, researchers describe what is currently known about allogenic hemopoietic stem cell transplant (HSCT) for myelofibrosis.

Hormonal contraceptive use among women of childbearing age was associated with a more than 2-fold higher risk of developing glaucoma, although risk was still relatively low.

As COVID-19 cases skyrocketed in the United States throughout the pandemic, incidences of other respiratory viral infections dramatically declined.

The new report may help explain why patients with psoriasis have a higher risk of cardiovascular problems.

Spinal cord stimulation (SCS) to treat pain in persons with multiple sclerosis (MS) was the focus of a recent literature review out of Italy.

David McIntyre, MD, FRACP, describes different methods of diagnosing gestational diabetes around the world.

PBMs keep copays higher on the same generic drugs.

Introducing more n-3 acids into one’s diet can mitigate headache pain for migraineurs.

However, researchers also noted that similar to chimeric antigen receptor (CAR) T-cell therapy, CAR-NK cell treatment comes with its own set of challenges.

A new review shows secukinumab continued to have a strong safety profile after 6 years on the market.

Gary Lyman, MD, MPH, an oncologist and hematologist, discusses how biosimilars have fared in the oncology space compared to other therapeutic areas.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Considerable evidence shows sodium-glucose co-transporter-2 inhibitors have cardioprotective benefits, but new research elucidates the ways in which the drugs can also have positive renal impacts.

Pfizer and BioNTech said they will seek approval for a booster shot of their COVID-19 mRNA vaccine, while US health authorities said a booster is not necessary. In addition, the CDC emphasized in-person learning for schools this fall in updated guidance.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

President Joe Biden is expected to sign an executive order aimed at lowering drug prices; the FDA imposes limits on who should receive a controversial new Alzheimer disease drug; western US states prepare for a second heat wave.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Posters presented at the European Hematology Association 2021 Virtual Congress evaluated acute myeloid leukemia (AML) in elderly patients.

This new study from Spain represents the first extensive look at late presentation of persons living with HIV, following the 2014 introduction of guidelines on early HIV diagnosis.

A lack of consensus for the term “immunocompromised” suggests that studies demonstrating the effectiveness of infection prevention in surgical patients at a high risk of wound infection may have limited relevancy.

A long-term Swedish study found that nonalcoholic fatty liver disease (NALFD) significantly increased mortality in children and young adults, particularly due to cancer, cardiometabolic disease, and liver disease.

An algorithm influenced by cough sound recognition and symptom reporting conducted using a smartphone was found to be effective at diagnosing patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

Psoriasis is prevalent among more than 7.5 million adults in the United States, a new study says.

The findings, coming from nearly a decade’s worth of retrospective data on patients aged at least 65 years, offer real-world evidence on the treatment’s impact on survival.

Moderna starts testing for its new mRNA seasonal flu vaccine; the worldwide COVID-19 death toll hits 4 million as Delta variant spreads; more states sign on to Purdue Pharma's bankruptcy reorganization plans after additional payments and release of documents are added to the deal.

Children exposed to environmental stressors known to impair sleep exhibited improved sleep duration by more than 1 hour each night after undergoing a mindfulness training intervention program, with rapid-eye movement sleep improving as well.

A meta-analysis from ESC Heart Failure shows the effects of home telemonitoring in patients with decompensated heart failure.